Imexpharm Corporation (HOSE: IMP)
Vietnam
· Delayed Price · Currency is VND 49,900
0.00 (0.00%)
At close: Oct 3, 2024
Imexpharm Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 2, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 7,685,047 | 3,962,167 | 4,013,628 | 5,187,048 | 3,753,609 | 2,370,593 | Upgrade
|
| Market Cap Growth | 29.61% | -1.28% | -22.62% | 38.19% | 58.34% | -21.20% | Upgrade
|
| Enterprise Value | 7,521,939 | 3,840,834 | 3,828,514 | 5,172,206 | 3,829,402 | 2,378,253 | Upgrade
|
| Last Close Price | 49900.00 | 25411.60 | 25370.47 | 32055.88 | 22762.30 | 14675.98 | Upgrade
|
| PE Ratio | 33.84 | 15.37 | 21.25 | 28.45 | 18.96 | 15.24 | Upgrade
|
| PS Ratio | 3.69 | 1.99 | 2.44 | 4.10 | 2.74 | 1.69 | Upgrade
|
| PB Ratio | 3.70 | 1.90 | 2.12 | 2.89 | 2.17 | 1.52 | Upgrade
|
| P/FCF Ratio | 449.19 | -38.44 | 14.37 | 28.50 | -227.06 | -36.73 | Upgrade
|
| P/OCF Ratio | 77.40 | -100.22 | 10.60 | 22.08 | 51.31 | 35.60 | Upgrade
|
| EV/Sales Ratio | 3.61 | 1.93 | 2.33 | 4.08 | 2.80 | 1.70 | Upgrade
|
| EV/EBITDA Ratio | 16.50 | 8.29 | 10.73 | 17.56 | 12.12 | 9.74 | Upgrade
|
| EV/EBIT Ratio | 21.38 | 10.08 | 12.91 | 22.10 | 14.59 | 11.71 | Upgrade
|
| EV/FCF Ratio | 439.66 | -37.27 | 13.71 | 28.41 | -231.65 | -36.85 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.02 | 0.05 | 0.15 | 0.08 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.21 | 0.11 | 0.27 | 0.90 | 0.41 | 0.15 | Upgrade
|
| Debt / FCF Ratio | 5.64 | -0.48 | 0.34 | 1.45 | -7.92 | -0.58 | Upgrade
|
| Asset Turnover | 0.83 | 0.85 | 0.72 | 0.58 | 0.69 | 0.77 | Upgrade
|
| Inventory Turnover | 1.64 | 1.78 | 1.78 | 1.46 | 1.94 | 2.26 | Upgrade
|
| Quick Ratio | 1.40 | 1.48 | 1.62 | 1.56 | 1.43 | 1.29 | Upgrade
|
| Current Ratio | 3.18 | 3.92 | 2.89 | 2.88 | 2.83 | 2.97 | Upgrade
|
| Return on Equity (ROE) | 13.43% | 15.06% | 12.12% | 10.73% | 12.75% | 10.60% | Upgrade
|
| Return on Assets (ROA) | 8.75% | 10.20% | 8.11% | 6.66% | 8.32% | 7.01% | Upgrade
|
| Return on Capital (ROIC) | 10.23% | 11.55% | 9.16% | 7.46% | 9.49% | 8.18% | Upgrade
|
| Earnings Yield | 2.96% | 7.56% | 5.57% | 3.65% | 5.59% | 6.85% | Upgrade
|
| FCF Yield | 0.22% | -2.60% | 6.96% | 3.51% | -0.44% | -2.72% | Upgrade
|
| Dividend Yield | 0.90% | 1.79% | 1.71% | 2.03% | 2.85% | 2.27% | Upgrade
|
| Payout Ratio | 24.70% | 22.26% | 44.74% | 52.89% | 23.55% | 60.84% | Upgrade
|
| Buyback Yield / Dilution | 2.93% | - | 0.00% | -2.92% | -0.86% | -0.01% | Upgrade
|
| Total Shareholder Return | 3.83% | 1.79% | 1.71% | -0.89% | 1.99% | 2.25% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.